Product Name | MF | CAS | Details |
---|
4,6-Dichloro-5-pyrimidinecarbaldehyde | C5H2Cl2N2O | 5305-40-8 | Details |
Pramipexole dihydrochloride monohydrate | C10H20ClN3OS | 191217-81-9 | Details |
2,3-DibroMo-4,5-diMethylpyridine | C7H7Br2N | 117846-57-8 | Details |
2-Chloro-3-iodo-4-methoxypyridine | C6H5ClINO | 1163693-01-3 | Details |
1-Ethyl-1H-1,2,3-triazole-4-carbaldehyde | C5H7N3O | 129027-63-0 | Details |
2-N-Propyl Pramipexole | C13H23N3S | 1246815-83-7 | Details |
Methyl 1,2,3-Triazole-4-carboxylate | C4H5N3O2 | 4967-77-5 | Details |
1,2,3-TRIAZOLE-4-CARBOXYLIC ACID | C3H3N3O2 | 16681-70-2 | Details |
Anacetrapib | C30H25F10NO3 | 875446-37-0 | Details |
1H-1,2,3-TRIAZOLE-4-METHANOL | C3H5N3O | 84440-19-7 | Details |
1-methyl-1H-1,2,3-Triazole-4-methanol | C4H7N3O | 77177-21-0 | Details |
1-(propan-2-yl)-1H-1,2,3-triazole-4-carbaldehyde | C6H9N3O | 129027-64-1 | Details |
2-Azidoethanol | C2H5N3O | 1517-05-1 | Details |
Cyclopentanethiol | C5H10S | 1679-07-8 | Details |
3-Bromopyruvic acid | C3H3BrO3 | 1113-59-3 | Details |
2-(3-Bromopropyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C9H18BBrO2 | 124215-44-7 | Details |
5,6-DICHLORO-1H-BENZIMIDAZOL-2-AMINE | C7H5Cl2N3 | 18672-03-2 | Details |
TETRAHYDRO-2-(2-PROPYNYLOXY)-2H-PYRAN | C8H12O2 | 6089-04-9 | Details |
TRIMETHYLSILYLMETHYL AZIDE | C4H11N3Si | 87576-94-1 | Details |
Trifluoromethanesulfonyl azide | 3855-45-6 | Details |
2,3,4,5-tetrafluoro-6-nitrobenzenaMine | C6H2F4N2O2 | 6157-98-8 | Details |
4,4'-Dithiobisbenzoic Acid, Technical Grade | C14H10O4S2 | 1155-51-7 | Details |
Hydrophobic-sub benzene disulfide analog | C20H26S2 | 7605-48-3 | Details |
Benzene,1,2,3,4-tetrafluoro-5,6-dinitro- | C6F4N2O4 | 16582-87-9 | Details |
2-(3-azidopropyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C9H18BN3O2 | 144266-69-3 | Details |
2-Bromo-3,4-difluoro-6-nitro-phenylamine | C6H3BrF2N2O2 | 112062-62-1 | Details |
2,1,3-Benzothiadiazole, 5,6-difluoro-1,3-dihydro- | C6H4F2N2S | 1333071-59-2 | Details |
2,3,4,5-Tetrafluoroaniline | C6H3F4N | 5580-80-3 | Details |
Veratraldehyde | C9H10O3 | 120-14-9 | Details |
TRIETHYLAMINE HYDROBROMIDE | C6H16BrN | 636-70-4 | Details |
Ethyl 2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylate | C13H13NO3S | 161797-99-5 | Details |
1,3-Dibromobenzene | C6H4Br2 | 108-36-1 | Details |
4-(difluoroMethyl)pyridin-2-aMine | C6H6F2N2 | 1346536-47-7 | Details |
3-BROMO-4,5-DIMETHYLPYRIDINE | C7H8BrN | 27063-98-5 | Details |
(4-Isopropyl)thiophenol | C9H12S | 4946-14-9 | Details |
4-Mercaptobenzoic acid | C7H6O2S | 1074-36-8 | Details |
3-Mercaptopropionic acid | C3H6O2S | 107-96-0 | Details |
(1-BROMONAPHTHALEN-4-YL)METHANOL | C11H9BrO | 56052-26-7 | Details |
Methyl 3-methoxypropionate | C5H10O3 | 3852-09-3 | Details |
5-Hydroxy-1,4-naphthalenedione | C10H6O3 | 481-39-0 | Details |
Dimethyl azelate | C11H20O4 | 1732-10-1 | Details |
tert-butyl 5-chloro-2-oxospiro[indoline-3,4'-piperidine]-1'-carboxylate | C17H21ClN2O3 | 2103402-31-7 | Details |
6,7-Dihydro-4(5H)-benzofuranone | C8H8O2 | 16806-93-2 | Details |
3,5-dibromo-1(3H)-Isobenzofuranone | C8H4Br2O2 | 102126-70-5 | Details |
Triphenylbismuth | C18H15Bi | 603-33-8 | Details |
3-bromo-1-methyl-1H-pyrazole | C4H5BrN2 | 151049-87-5 | Details |
1-Methyl-3-pyrrolidinol | C5H11NO | 13220-33-2 | Details |
ISOPROPYL TRIFLUOROACETATE | C5H7F3O2 | 400-38-4 | Details |
Ethyl 4-chloroacetoacetate | C6H9ClO3 | 638-07-3 | Details |
Crizotinib | C21H22Cl2FN5O | 877399-52-5 | Details |
Tirzepatide | 2023788-19-2 | Details |
ANGIOTENSIN II, HUMAN | C50H71N13O12 | 4474-91-3 | Details |
Epitalon | C14H22N4O9 | 307297-39-8 | Details |
4(3H)-Pyrimidinone, 5-methyl-2-(methylthio)- | C6H8N2OS | 20651-30-3 | Details |
Dabrafenib | C23H20F3N5O2S2 | 1195765-45-7 | Details |
15-Azido-4,7,10,13-tetraoxapentadecanoic acid | C11H21N3O6 | 1257063-35-6 | Details |
2-Hexenoic acid, 6-bromo-, ethyl ester, (E)- | C8H13BrO2 | 71032-10-5 | Details |
1-Azabicyclo[3.2.1]octane-6-carboxylic acid, ethyl ester, (1R,5R,6R)-rel- | C10H17NO2 | 115594-92-8 | Details |
(S)-(-)-Methylsuccinic acid | C5H8O4 | 2174-58-5 | Details |
2-Hexenoic acid, 6-bromo-, ethyl ester | C8H13BrO2 | 197449-13-1 | Details |
Carbamic acid, N-[(1S)-2-[3,5-bis(trifluoromethyl)phenyl]-2-hydroxy-1-methylethyl]-, phenylmethyl ester | C19H17F6NO3 | 1182350-90-8 | Details |
1,6-Naphthyridin-2(1H)-one, 4-hydroxy- | C8H6N2O2 | 60058-17-5 | Details |
3-METHYLADENINE | C6H7N5 | 5142-23-4 | Details |
4-METHYL-4-PHENYLPENTAN-2-ONE | C12H16O | 7403-42-1 | Details |
2-Oxazolidinone, 5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-, (4S,5R)- | C12H9F6NO2 | 875444-08-9 | Details |
2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole | C7H11N3S | 104617-49-4 | Details |
1,6-Naphthyridine-3-carboxylic acid, 1,2-dihydro-4-hydroxy-2-oxo-, ethyl ester | C11H10N2O4 | 72668-49-6 | Details |
CarbaMic acid, N-[(1S)-2-[3,5-bis(trifluoroMethyl)phenyl]-1-Methyl-2-oxoethyl]-, phenylMethyl ester | C19H15F6NO3 | 871917-79-2 | Details |
4-bromobutyraldehyde | C4H7BrO | 38694-47-2 | Details |
2-(4-MethoxybenzylaMino)acetonitrile | C10H12N2O | 63086-28-2 | Details |
BMN 673 | C19H14F2N6O | 1207456-01-6 | Details |
XL518 | C21H21F3IN3O2 | 934660-93-2 | Details |
Lumacaftor (VX-809) | C24H18F2N2O5 | 936727-05-8 | Details |
Carfilzomib | C40H57N5O7 | 868540-17-4 | Details |
Bictegravir | C21H18F3N3O5 | 1611493-60-7 | Details |
Eluxadoline | C32H35N5O5 | 864821-90-9 | Details |
Baricitinib | C16H17N7O2S | 1187594-09-7 | Details |
Elagolix Sodium | C32H29F5N3NaO5 | 832720-36-2 | Details |
MK5172 | C38H50N6O9S | 1350514-68-9 | Details |
3-Hydroxyphthalic anhydride | C8H4O4 | 37418-88-5 | Details |
Tamibarotene | C22H25NO3 | 94497-51-5 | Details |
ABT-530 | C57H65F5N10O8 | 1353900-92-1 | Details |
Neratinib | C30H29ClN6O3 | 698387-09-6 | Details |
Lorlatinib | C21H19FN6O2 | 1454846-35-5 | Details |
(S)-2-{[(((1R,2R)-2-(allyloxy)cyclopentyl)oxy)carbonyl]amino}-3,3-dimethylbutanoic acid | C15H25NO5 | 1365970-45-1 | Details |
Firocoxib | C17H20O5S | 189954-96-9 | Details |
Oclacitinib | C15H23N5O2S | 1208319-26-9 | Details |
Baloxavir | C24H19F2N3O4S | 1985605-59-1 | Details |
Metaraminol bitartrate | C13H19NO8 | 33402-03-8 | Details |
Brigatinib | C29H39ClN7O2P | 1197953-54-0 | Details |
1-Piperidineethanol, 2-(3-hydroxy-3-azetidinyl)-β-phenyl-, hydrochloride (1:2), (βS,2S)- | C16H25ClN2O2 | 2058310-62-4 | Details |
(R)-1-(2,6-Dichloro-3-fluorophenyl)ethanol | C8H7Cl2FO | 330156-50-8 | Details |
1-(2,6-DICHLORO-3-FLUOROPHENYL)ETHANOL | C8H7Cl2FO | 756520-66-8 | Details |
4-(1-(1-ethoxyethyl)-1H-pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine | C19H29N5O2Si | 1187595-88-5 | Details |
(3S 5R 8AS)-(+)-HEXAHYDRO-3-PHENYL-5H-O& | C14H16N2O | 106565-71-3 | Details |
(S)-1-(2,6-Dichloro-3-fluorophenyl)ethanol | C8H7Cl2FO | 877397-65-4 | Details |
(4S,5R)-(-)-4-METHYL-5-PHENYL-2-OXAZOLIDINONE | C10H11NO2 | 16251-45-9 | Details |
(1S-cis)-4-Amino-2-cyclopentene-1-methanol D-hydrogen tatrate | C10H17NO7 | 229177-52-0 | Details |
2,4-Imidazolidinedione,5-(4-hydroxyphenyl)- | C9H8N2O3 | 2420-17-9 | Details |
(R)-5-bromo-3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]pyridin-2-amine | C13H10BrCl2FN2O | 877399-00-3 | Details |
Product Total: Product Page: | ||||
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 |